Sandoz Group (OTCMKTS:SDZNY) Sees Strong Trading Volume - Still a Buy?

Key Points

• Sandoz Group experienced a 33% increase in trading volume, with approximately 43,305 shares traded compared to 32,448 shares previously.
• Jefferies Financial Group downgraded Sandoz Group's rating from "strong-buy" to "hold," now reflecting an average rating of "Hold" from three investment analysts.
• The company's current stock price is $59.69, slightly down from its previous close of $60.72, indicating potential interest for buyers.

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) saw an uptick in trading volume on Thursday . 43,305 shares changed hands during mid-day trading, an increase of 33% from the previous session's volume of 32,448 shares.The stock last traded at $59.69 and had previously closed at $60.72.

Analysts Set New Price Targets

Separately, Jefferies Financial Group downgraded Sandoz Group from a "strong-buy" rating to a "hold" rating in a report on Friday, August 8th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of "Hold".

Sandoz Group Stock Up 1.2%

The company has a quick ratio of 0.79, a current ratio of 1.24 and a debt-to-equity ratio of 0.57. The company has a 50 day moving average price of $59.66 and a 200-day moving average price of $51.06.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.